Effect of patient-controlled analgesia after thoracoscopic lung surgery
Conditions
Interventions
Group O:The scheme of patient-controlled analgesia pump was oselidine 0.3mg/kg (total 100ml)
Group S:The patient-controlled analgesia program was sufentanil 3ug/kg (total 100ml).
Sponsors
Nanpi people's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. age 18-75 years old; 2. patients who plan to undergo thoracoscopic surgery and need patient-controlled intravenous analgesia after surgery. 3. ASA I-III; 4. voluntarily participate in and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. chronic pain, long-term use of analgesics, psychotropic drugs (including opioids, NSAIDs, sedatives, antidepressants), alcohol abuse; 2. allergic to the study drug; 3. BMI>35kg/m2 or bmi<18.5kg/m2; 4. shock, mental disorder, cognitive impairment and other patients who cannot cooperate; 5. severe heart or liver disease; 6. acute and chronic bronchial asthma; 7. suspected gastrointestinal obstruction; 8. pregnant women or puerpera; 9. sleep apnea; 10. participated in other drug trials within three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative nausea and vomiting score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score;IV-PCA cumulative press times;Total use of analgesic pump;Patient satisfaction score; | — |
Countries
China
Contacts
Public ContactLi Xiaobin
Nanpi people's Hospital
Outcome results
None listed